ABM Industries, Inc. (ABM)
NYSEIndustrialsSpecialty Business ServicesSnapshot 2026-09-09
$49.74-1.70%
Close 2026-09-09 · 1-day change
NYSEIndustrialsSpecialty Business ServicesSnapshot 2026-09-09
Warn: Primary pillar under pressure — Maintain operating margin near 7.8% to 8.0%: 3.9% vs 7.8% target.
ABM aims for 4% to 5% revenue growth in 2026. Profit margin is expected near 8%. The company maintains EPS guidance of $3.85 to $4.15. Dividend stays steady at $0.29 per share.
Revenue growth has been weak recently with some quarters showing declines. EPS performance is mixed and guidance was cut recently. Management has shown volatility, which may hurt execution.
The price is about 39% below our fair value near $73. Analysts expect about 4% revenue growth, which aligns with management targets. Our view is cautious given recent guidance cuts and mixed execution.
Breaks if: Dividend per share falls below $0.29
Breaks if: EPS guidance falls below $3.85 for FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on steady revenue growth and dividend maintenance. The current thesis state is mixed, as management has reaffirmed growth and earnings targets despite recent performance challenges.
The market appears to price in a cheap valuation compared to peers, with expectations that are somewhat lower than what management has guided. The fragility in earnings quality suggests that investors are cautious about future performance.
Fundamentals may struggle to show significant improvement in the near term, given the mixed results and recent earnings misses. Management's focus on achieving revenue growth and maintaining EPS guidance indicates a commitment to improving performance, but recent results have not yet reflected this.
The long-term thesis hinges on the performance of sector bellwethers like CTAS, CPRT, and ROL, which could impact ABM's momentum. Additionally, any changes in guidance during upcoming earnings calls could significantly affect investor sentiment.
The most important moves since the prior daily snapshot.
Company momentum fell by 36.0 points (from 9.3 to -26.7).
Yes, our read has strengthened. The company reported record revenue of $2.3 billion. This is a 4.2% increase year-over-year. It also raised full-year EPS guidance to $3.85 to $4.15. There are no new threats to the thesis. The market is focused on margin improvement after previous earnings challenges.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Reaffirm adjusted EPS guidance in the range of $3.85 to $4.15 for fiscal year 2026, reflecting confidence in earnings performance.
Stated as a priority in 3 of last 3 quarters. Adjusted EPS guidance remained in the $3.85 to $4.15 range, with the midpoint raised to $4.025 in 2026-Q3. Actual diluted EPS grew from $0.64 in 2026-Q1 to $0.84 in 2026-Q3, indicating progress toward the annual EPS target.
“The Company is raising the midpoint of its adjusted EPS outlook. The range is now $3.95 to $4.10, versus the previous range of $3.85 to $4.15.”
“Adjusted EPS is still expected to be in the range of $3.85 to $4.15.”
“Adjusted EPS is expected to be in the range of $3.85 to $4.15.”
Breaks if: Operating margin falls below 7.5% in FY26 Q4
Breaks if: YoY revenue growth falls below 4% in FY26
Deliver total revenue growth toward the top end of the 4% to 5% range for fiscal year 2026, including organic growth and acquisition contributions.
Stated as a priority in 3 of last 3 quarters. Revenue grew from $2.22 billion in 2025-Q3 to $2.32 billion in 2026-Q3, a 4.2% increase. Management consistently expects total revenue growth toward the top end of the 4% to 5% range for fiscal 2026, reflecting delivery on this priority.
“Revenue increased 4.2% to a quarterly record of $2.3 billion, including organic growth of 2.1% and acquisition-related growth of 2.1%”
“The Company now expects organic revenue growth toward the top end of the 3% to 4% range and total revenue growth toward the top end of the 4% to 5% range.”
“The Company continues to expect organic revenue growth of 3% to 4% and total revenue growth of 4% to 5%.”
Over the next 1 to 3 years, ABM's outlook remains cautious due to mixed fundamentals and sector headwinds. Not investment advice.